A Randomised Phase II Study Comparing Anastrozole and Fulvestrant to Anastrozole for Adjuvant Treatment of Postmenopausal Patients With Early Breast Cancer and Disseminated Tumour Cells in Bone Marrow.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Anastrozole; Fulvestrant
- Indications Early breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2008 Preliminary data on the frequency of bone marrow micrometastasis in 13 patients was presented at the 31st Annual San Antonio Breast Cancer Symposium.
- 01 Nov 2006 New trial record.